摘要
大多数肿瘤都有多药耐药-1(MDR-1)基因的过度表达,其表达产物P-糖蛋白(P-gp)在肿瘤的耐药机制中起着关键作用,对P-gp表达的预测在化疗中至关重要,99Tcm-甲氧基异丁基异腈(99Tcm-MIBI)转运分析可作为探测低水平的P-gp表达和定量评价调节转运的敏感指标,指导应用调节剂改善化疗效果。
There has a overexpression ofmultidrug resistance (MDR) gene in most tumor. It is very important that it's expression product P-glycoprotein(P-gp)in multidrug resistance machine of tumor. The anticipation for P-gp expression is significance for chemotherapy. The conveying analysis of ^99Tc^m-sestamibi (^99Tc^m-MIBI) is a sensitiveness index for low-level P-gp expression.
出处
《国外医学(放射医学核医学分册)》
2005年第4期169-170,共2页
Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)